Sino Biopharmaceutical to Receive $358 Million in Payments
Sino Biopharmaceutical says SBP Group is to receive $358 million in upfront and near-term payments.
Sino Biopharmaceutical says SBP Group is to receive $358 million in upfront and near-term payments.